Rotherham, Doncaster and South Humber NHS Foundation Trust patient group directions for the inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV).
This group direction is for the administration of inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV) nasal spray suspension to individuals in accordance with the national influenza immunisation programme and applicable service specifications.
To access this document, refer to the inactivated influenza vaccine and live attenuated influenza vaccine (staff access only).
To access the equality impact assessment for this policy, please email rdash.equalityanddiversity@nhs.net to request the document.
Page last reviewed: July 30, 2026
Next review due: July 30, 2027
Problem with this page?
Please tell us about any problems you have found with this web page.